Dermatology

Eur Rev Med Pharmacol Sci 2023; 27 (9): 4060-4064
DOI: 10.26355/eurrev_202305_32312

Long-term clinical efficacy and safety of ixekizumab for psoriatic patients: a single-center experience

M. Burlando, I. Salvi, R. Castelli, A. Herzum, E. Cozzani, A. Parodi
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (7): 2881-2887
DOI: 10.26355/eurrev_202304_31919

Evaluation of nail psoriasis with ultrasound enhanced blood flow imaging (eflow) and Power Doppler (PD)

Y.-K. Zhang, W.-J. Li, W. Chen
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (4): 1450-1466
DOI: 10.26355/eurrev_202302_31385

Synergistic use of bioactive agents for the management of different skin conditions: an overview of biological activities

M. Baldi, R. Reynaud, F. Lefevre, M. Fleury, A. Scandolera, G. Maramaldi
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (3): 1023-1026
DOI: 10.26355/eurrev_202302_31197

Treatment of erosive pustular dermatosis of the scalp: our experience and review of unconventional topical drugs

L. Di Bartolomeo, I. Ceravolo, F. Borgia, F. Vaccaro, C. Guarneri, M. Vaccaro
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (2): 713-727
DOI: 10.26355/eurrev_202301_31074

Role of sphingosine-1-phosphate receptors in the tumor microenvironment: prospects for cancer immunotherapy

Z. Wang, H.-M. Zhang, Y.-R. Guo, L.-L. Li, G.-Z. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (1): 437-441
DOI: 10.26355/eurrev_202301_30900

An impressive case of alopecia universalis after COVID-19 vaccination: a coincidental finding or a consequence?

L. Peterle, L. Macca, F. Li Pomi, F. Vaccaro, F. Borgia, M. Vaccaro
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (1): 66-73
DOI: 10.26355/eurrev_202301_30853

mRNA and long-noncoding RNA signatures for improving the prognosis prediction of cutaneous skin melanoma efficiently

S.-X. Zi, Y.-M. Xing, C.-Z. Wang
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (24): 9437-9446
DOI: 10.26355/eurrev_202212_30695

Development of a prognostic prediction model for patients with cutaneous malignant melanoma: a study based on the SEER database

X.-Y. He, Y.-F. Gao, Y.-P. Huang, X.-W. Zou, D. Wang, H. Su
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (23): 8788-8794
DOI: 10.26355/eurrev_202212_30550

Tuberculosis screening guidelines should be updated and quantiferon test should be a prerequisite prior to the initiation of treatment of psoriasis with biological agents

F. Tamer, A. Gulekon
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (21): 8118-8128
DOI: 10.26355/eurrev_202211_30166

Mogamulizumab and bexarotene are a promising association for the treatment of advanced cutaneous T-cell lymphomas: a case series

M. Teoli, V.D. Mandel, C. Franceschini, P.L. Saraceni, M.P. Cicini, M. Ardigò
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (19): 7305-7312
DOI: 10.26355/eurrev_202210_29925

Factors aggravating acne vulgaris during the COVID-19 pandemic in China: a web-based cross-sectional survey

Y.-F. Cheng, H. Zhao, J. Li, K.E. Lipa, H.-F. Xie, B. Wang, Y.-X. Huang
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (18): 6827-6836
DOI: 10.26355/eurrev_202209_29785

Pharmacological basis of the putative therapeutic effect of Topical Vitamin D3 on the experimental model of atopic dermatitis in mice

N.S. Alosaimi, M.A.A. Sattar Ahmad, H.M. Alkreathy, A.S. Ali, L.M. Khan
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (18): 6772-6776
DOI: 10.26355/eurrev_202209_29777

Psoriasis patients’ characteristics associated with high PASI response to tildrakizumab: an international dual center study

M. Burlando, J.-T. Maul, I. Salvi, D. Simic, E. Cozzani, M. Ak, I. Birkenmaier, A. Parodi
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (15): 5353-5361
DOI: 10.26355/eurrev_202208_29401

Risk factors and psychological condition of pruritus in type 2 diabetes mellitus: a retrospective, propensity score-matched study

Y.-Y. Chen, Q.-P. Yang, S.-P. Peng, Z.-Z. Li, H.-Y. Yang, X.-G. Fan, M.-M. Xu
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (14): 5033-5042
DOI: 10.26355/eurrev_202207_29289

Targeted screening and quantification of synthetic cathinones and metabolites in hair by UHPLC-HRMS

N. La Maida, G. Mannocchi, S. Pichini, G. Basile, A. Di Giorgi, F.P. Busardò, E. Marchei
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (12): 4367-4370
DOI: 10.26355/eurrev_202206_29075

Acrokeratosis of Bazex as a sign of thyroid cancer: first description and review of thyroid-associated paraneoplastic dermatoses

L. Macca, L. Manuella, R. Taibi, C. Guarneri
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (12): 4159-4160
DOI: 10.26355/eurrev_202206_29051

The unexpected regression of melanocytic naevi

L. Macca, A. Motolese, R. Taibi, C. Guarneri
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (7): 2518-2523
DOI: 10.26355/eurrev_202204_28489

Topical tacrolimus during systemic therapy for severe atopic dermatitis in the clinical practice

S.M. Ferrucci, L. Angileri, A.V. Marzano, E. Berti, S. Tavecchio
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (6): 2018-2024
DOI: 10.26355/eurrev_202203_28350

Proactive vs. reactive psoriasis therapy: a long-term evaluation with dermoscopic and confocal microscopy assessment

S. Cacciapuoti, A. Ruggiero, L. Gallo, G. Fabbrocini
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (5): 1695-1700
DOI: 10.26355/eurrev_202203_28238

The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review

B. Fionda, A. Di Stefani, V. Lancellotta, S. Gentileschi, A.A. Caretto, C. Casà, F. Federico, A. Rembielak, E. Rossi, A.G. Morganti, G. Schinzari, K. Peris, L. Tagliaferri
Free PDF Download